IAP antagonists synergise with IFNy to activate novel RIPK1 and caspase mediated death pathways in cancer cell lines

Submission note: A thesis submitted in total fulfilment of the requirement for the degree of Doctor of Philosophy to the School of Molecular Sciences, Faculty of Science, Technology and Engineering, La Trobe University, Bundoora